Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.23 CAD -4.44% Market Closed
Market Cap: 88.5m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Covalon Technologies Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Total Current Assets
CA$23.3m
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
13%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Total Current Assets
CA$20m
CAGR 3-Years
184%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Total Current Assets
$57.2m
CAGR 3-Years
-16%
CAGR 5-Years
-4%
CAGR 10-Years
16%
ESSA Pharma Inc
NASDAQ:EPIX
Total Current Assets
$127.6m
CAGR 3-Years
-14%
CAGR 5-Years
19%
CAGR 10-Years
42%
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Current Assets
$440.5m
CAGR 3-Years
10%
CAGR 5-Years
26%
CAGR 10-Years
28%
Spectral Medical Inc
TSX:EDT
Total Current Assets
CA$7.3m
CAGR 3-Years
-17%
CAGR 5-Years
14%
CAGR 10-Years
-6%
No Stocks Found

Covalon Technologies Ltd
Glance View

Market Cap
88.5m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.73 CAD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Covalon Technologies Ltd's Total Current Assets?
Total Current Assets
23.3m CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Total Current Assets amounts to 23.3m CAD.

What is Covalon Technologies Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
13%

Over the last year, the Total Current Assets growth was 1%. The average annual Total Current Assets growth rates for Covalon Technologies Ltd have been 14% over the past three years , 6% over the past five years , and 13% over the past ten years .

Back to Top